跳至主要内容
临床试验/EUCTR2005-000904-15-IT
EUCTR2005-000904-15-IT进行中(未招募)不适用

ew onset type 1 diabetes Mycophenolate Mofetil Daclizumab clincal trial - MMF/DZB in T1DM

IDDK TYPE 1 DIABETES TRIALNET0 个研究点目标入组 126 人开始时间: 2007年12月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Type 1 diabetes within 3 months of diagnosis; Between the ages of 18 and 45 years; Stimulated C-peptide ≥ 0.2 pmol/ml; Detectable beta cell autoantibodies.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Complicating Medical conditions; Serologic evidence of HIV, HCV or Hep B, History of leucopenia and/or neutropenia; Abnormal liver function tests; Positive PPD; Live vaccinations in 6 weeks preceeding randomizzation; Refusal to use birth control; Pregnancy/ nursing/ 3 months post partum

研究者

发起方
IDDK TYPE 1 DIABETES TRIALNET

相似试验